| hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells. | hnRNPA0 promotes MYB expression by interacting with enhancer lncRNA MY34UE-AS in human leukemia cells.
Liu C, Wang Y, Shi M, Tao X, Man D, Zhang J, Han B. | 07/12/2024 |
| Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements. | Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.
Feinberg J, Da Cruz Paula A, da Silva EM, Pareja F, Patel J, Zhu Y, Selenica P, Leitao MM Jr, Abu-Rustum NR, Reis-Filho JS, Joehlin-Price A, Weigelt B., | 06/28/2024 |
| lncRNA SNHG4 inhibits ferroptosis by orchestrating miR-150-5p/c-Myb axis in colorectal cancer. | lncRNA SNHG4 inhibits ferroptosis by orchestrating miR-150-5p/c-Myb axis in colorectal cancer.
Li SQ, Lv F, Xu WT, Yin YX, Wei HT, Li KZ, Hu BL. | 06/3/2024 |
| From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies. | From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies.
Anand S, Vikramdeo KS, Sudan SK, Sharma A, Acharya S, Khan MA, Singh S, Singh AP., Free PMC Article | 04/17/2024 |
| MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature. | MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J, Fehr A, Jäwert F, Nilsson JA, Morris LGT, Stenman G, Andersson MK. | 04/11/2024 |
| MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma. | MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.
Cheng L, Deng X, Le Y. | 03/22/2024 |
| The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. | The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.
Cicirò Y, Ragusa D, Nevado PT, Lattanzio R, Sala G, DesRochers T, Millard M, Andersson MK, Stenman G, Sala A. | 02/5/2024 |
| Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression. | Solid-Basaloid Adenoid Cystic Carcinoma of the Breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
Shamir ER, Bean GR, Schwartz CJ, Vohra P, Wang A, Allard GM, Wolsky RJ, Garcia JJ, Chen YY, Krings G. | 01/3/2024 |
| Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML. | Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.
Negri A, Ward C, Bucci A, D'Angelo G, Cauchy P, Radesco A, Ventura AB, Walton DS, Clarke M, Mandriani B, Pappagallo SA, Mondelli P, Liao K, Gargano G, Zaccaria GM, Viggiano L, Lasorsa FM, Ahmed A, Di Molfetta D, Fiermonte G, Cives M, Guarini A, Vegliante MC, Ciavarella S, Frampton J, Volpe G., Free PMC Article | 12/1/2023 |
| LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis. | LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis.
Wang J, Han Y, Zhang T, Li J, Xu B. | 11/8/2023 |
| MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape. | MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
Lemma RB, Ledsaak M, Fuglerud BM, Rodríguez-Castañeda F, Eskeland R, Gabrielsen OS., Free PMC Article | 10/4/2023 |
| rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4[+] T Cells via Disruption of c-Myb Binding. | rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4(+) T Cells via Disruption of c-Myb Binding.
Uvarova AN, Stasevich EM, Ustiugova AS, Mitkin NA, Zheremyan EA, Sheetikov SA, Zornikova KV, Bogolyubova AV, Rubtsov MA, Kulakovskiy IV, Kuprash DV, Korneev KV, Schwartz AM., Free PMC Article | 09/30/2023 |
| Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites. | Gallbladder cancer-associated genetic variants rs1003349 and rs1004030 regulate MMP14 expression by altering SOX10- and MYB-binding sites.
J V, Palo A, Besra K, Dixit M. | 07/12/2023 |
| Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases. | Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.
Kalelioglu T, Rama B, Cho BB, Lopes BM, Patel SH., Free PMC Article | 03/23/2023 |
| C/EBPbeta cooperates with MYB to maintain the oncogenic program of AML cells. | C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells.
Klempnauer KH., Free PMC Article | 03/20/2023 |
| Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer. | Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer.
Acharya S, Anand S, Khan MA, Zubair H, Srivastava SK, Singh S, Singh AP., Free PMC Article | 02/4/2023 |
| MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells. | MYB and ELF3 differentially modulate labor-inducing gene expression in myometrial cells.
Shchuka VM, Khader N, Dorogin A, Shynlova O, Mitchell JA., Free PMC Article | 01/11/2023 |
| Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia. | Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.
Song H, Liu Y, Tan Y, Zhang Y, Jin W, Chen L, Wu S, Yan J, Li J, Chen Z, Chen S, Wang K., Free PMC Article | 09/24/2022 |
| LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome. | LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome.
Liu Z, Wang P, Yuan S, Wang Y, Cao P, Wen F, Li H, Zhu L, Liang L, Wang Z, Hu B, Zheng F, Liu J, Xiao X, Zhang J., Free PMC Article | 04/16/2022 |
| c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. | c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
Zhang L, Wang X, Li Y, Han J, Gao X, Li S, Wang F., Free PMC Article | 02/12/2022 |
| Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences. | Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences.
Ganel L, Chen L, Christ R, Vangipurapu J, Young E, Das I, Kanchi K, Larson D, Regier A, Abel H, Kang CJ, Scott A, Havulinna A, Chiang CWK, Service S, Freimer N, Palotie A, Ripatti S, Kuusisto J, Boehnke M, Laakso M, Locke A, Stitziel NO, Hall IM., Free PMC Article | 02/5/2022 |
| circFAT1(e2) Inhibits Cell Apoptosis and Facilitates Progression in Vascular Smooth Muscle Cells through miR-298/MYB Axis. | circFAT1(e2) Inhibits Cell Apoptosis and Facilitates Progression in Vascular Smooth Muscle Cells through miR-298/MYB Axis.
Shi Z, Ye S, Xiang Y, Wu D, Xu J, Yu J, Zeng C, Jiang J, Hu W., Free PMC Article | 02/5/2022 |
| MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia. | MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Bardelli V, Arniani S, Pierini V, Pierini T, Di Giacomo D, Gorello P, Moretti M, Pellanera F, Elia L, Vitale A, Storlazzi CT, Tolomeo D, Mastrodicasa E, Caniglia M, Chiaretti S, Ruggeri L, Roti G, Schwab C, Harrison CJ, Almeida A, Pieters T, Van Vlierberghe P, Mecucci C, La Starza R. | 02/5/2022 |
| Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner. | Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.
Yusenko MV, Biyanee A, Andersson MK, Radetzki S, von Kries JP, Stenman G, Klempnauer KH. | 01/8/2022 |
| Dissecting the transactivation domain (tAD) of the transcription factor c-Myb to assess recent models of tAD function. | Dissecting the transactivation domain (tAD) of the transcription factor c-Myb to assess recent models of tAD function.
Naes G, Storesund JO, Udayakumar PD, Ledsaak M, Gabrielsen OS., Free PMC Article | 11/27/2021 |